HomeOrderingContact UsAbout UsInvestor InformationSite Map

Press Releases

Archived Press Releases

For information regarding press releases please contact us at:
Phone: (402) 452-5437
Fax: (402) 452-5461
E-mail: investorrelations@transgenomic.com

Disclaimer

The following historical press releases contain statements that reflected management's views and estimates of future economic circumstances, industry conditions, company performance and financial results applicable on the dates they were first issued. Investors should not assume that statements made in these documents remain accurate and complete as of any later date.

Such statements were and remain subject to certain factors, risks and uncertainties, including those described in Transgenomic, Inc.'s reports to the Securities and Exchange Commission. Any change in such factors, risks and uncertainties could have caused the actual results, events and performance to differ materially from those referred to in such statements.

Transgenomic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any of these documents to reflect any change in Transgenomic's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements were based.

Available Archives
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
2009 Archive
December 17, 2009ViewTransgenomic, Inc. Executes License Option Agreement for Parkinson’s Disease Diagnostic Markers with Gene Solutions, LLC
 
December 8, 2009ViewTransgenomic Announces the Commercial Launch of SURVEYOR® Scan K-RAS Mutation Detection Kit
 
November 5, 2009ViewTransgenomic, Inc. Reports Third Quarter 2009 Results
 
November 5, 2009ViewReminder Webcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
 
October 29, 2009ViewWebcast Alert: Transgenomic, Inc. Announces Third Quarter 2009 Earnings Release Conference Call Webcast
 
October 8, 2009ViewTransgenomic Signs Exclusive License for Cold-PCR Technology from the Dana-Farber Cancer Institute
 
September 2, 2009ViewTransgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinson’s Disease
 
August 12, 2009ViewTransgenomic, Inc. Reports Second Quarter 2009 Results
 
August 12, 2009ViewReminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
 
August 6, 2009ViewWebcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
 
May 22, 2009ViewTransgenomic, Inc. Announces Appointment of New Board Members
 
May 13, 2009ViewTransgenomic, Inc. Reports First Quarter 2009 Results
 
May 13, 2009ViewReminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
 
May 11, 2009ViewTransgenomic and Power3 Medical Introduce NuroPro® Tests for Alzheimer’s and Parkinson’s Diseases at AAN Annual Meeting
 
May 7, 2009ViewWebcast Alert: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
 
April 7, 2009ViewTransgenomic Completes Licensing Option with Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations
 
April 2, 2009ViewPolycystic Kidney Disease Assay at Cornell University uses Transgenomic’s Surveyor Nuclease & WAVE Technology
 
March 18, 2009ViewTransgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
 
March 18, 2009ViewReminder - Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast
 
March 11, 2009ViewWebcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast
 
March 5, 2009ViewTransgenomic Awarded Clinical Laboratory Certification in California
 
February 23, 2009ViewWebcast Alert Cancellation: Transgenomic Inc. Cancels Fourth Quarter 2008 Earnings Release Conference Call Webcast
 
February 18, 2009ViewWebcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast
 
February 2, 2009ViewTransgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
 
Press Releases
 
Contact WebmasterSend Page To ColleaguePrintable PageChange Country United States
Copyright © 1997-2010 Transgenomic, Inc., All Rights Reserved.the power of discovery™